These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 21438201)

  • 1. [Antibiotics in the critically ill].
    Kolak RR
    Med Pregl; 2010; 63 Suppl 1():27-32. PubMed ID: 21438201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study.
    Alvarez-Lerma F; Alvarez B; Luque P; Ruiz F; Dominguez-Roldan JM; Quintana E; Sanz-Rodriguez C;
    Crit Care; 2006; 10(3):R78. PubMed ID: 16704742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Principles of antibiotic therapy in severe infections: optimizing the therapeutic approach by use of laboratory and clinical data.
    Deresinski S
    Clin Infect Dis; 2007 Sep; 45 Suppl 3():S177-83. PubMed ID: 17712744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing antibiotic therapy in the intensive care unit setting.
    Kollef MH
    Crit Care; 2001 Aug; 5(4):189-95. PubMed ID: 11511331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of antimicrobial therapy in intensive care units.
    Textoris J; Wiramus S; Martin C; Leone M
    Expert Rev Anti Infect Ther; 2011 Jan; 9(1):97-109. PubMed ID: 21171881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of broad-spectrum antimicrobials for the treatment of pneumonia in seriously ill patients: maximizing clinical outcomes and minimizing selection of resistant organisms.
    Niederman MS
    Clin Infect Dis; 2006 Jan; 42 Suppl 2():S72-81. PubMed ID: 16355320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Strategies targeted at optimising antimicrobial therapy in critically ill patients].
    Eggimann P; Oddo M; Voirol P; Zanetti G; Chioléro R
    Rev Med Suisse; 2005 Dec; 1(45):2928-32. PubMed ID: 16425950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current guidelines for the treatment of severe pneumonia and sepsis.
    Bodmann KF
    Chemotherapy; 2005 Aug; 51(5):227-33. PubMed ID: 16103664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic therapy in patients with septic shock.
    Textoris J; Wiramus S; Martin C; Leone M
    Eur J Anaesthesiol; 2011 May; 28(5):318-24. PubMed ID: 21464717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic selection and pharmacokinetics in the critically ill.
    Bush LM; Levison ME
    Crit Care Clin; 1988 Apr; 4(2):299-324. PubMed ID: 3048589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic usage in intensive care units: a pharmaco-epidemiological multicentre study.
    Malacarne P; Rossi C; Bertolini G;
    J Antimicrob Chemother; 2004 Jul; 54(1):221-4. PubMed ID: 15190030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial resistance: factors and outcomes.
    Fish DN; Ohlinger MJ
    Crit Care Clin; 2006 Apr; 22(2):291-311, vii. PubMed ID: 16678001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De-escalation antimicrobial chemotherapy in critically III patients: pros and cons.
    Antonelli M; Mercurio G; Di Nunno S; Recchioni G; Deangelis G
    J Chemother; 2001 Nov; 13 Spec No 1(1):218-23. PubMed ID: 11936369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial resistance: consideration as an adverse drug event.
    Martin SJ; Micek ST; Wood GC
    Crit Care Med; 2010 Jun; 38(6 Suppl):S155-61. PubMed ID: 20502169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empirical use of antibiotics and adjustment of empirical antibiotic therapies in a university hospital: a prospective observational study.
    Mettler J; Simcock M; Sendi P; Widmer AF; Bingisser R; Battegay M; Fluckiger U; Bassetti S
    BMC Infect Dis; 2007 Mar; 7():21. PubMed ID: 17386104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Can one use probabilistic protocols for antibiotic therapy in intensive care units?].
    Bourdain N; Lepape A; Galzot F; Lamy B; Haessler D; Chomarat M; Grozel JM; Banssillon V
    Pathol Biol (Paris); 1999 May; 47(5):584-8. PubMed ID: 10418047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do cultures contribute to optimisation of antibiotic therapy in the intensive care unit?
    Schurink CA; Hoitsma M; Rozenberg-Arska M; Joore JC; Hoepelman IM; Bonten MJ
    Int J Antimicrob Agents; 2004 Apr; 23(4):325-31. PubMed ID: 15081079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of severe bacterial infections.
    Esposito S; Leone S; Noviello S
    Expert Rev Anti Infect Ther; 2005 Aug; 3(4):593-600. PubMed ID: 16107198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic stewardship in the intensive care unit.
    Luyt CE; Bréchot N; Trouillet JL; Chastre J
    Crit Care; 2014 Aug; 18(5):480. PubMed ID: 25405992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.